Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Minna Sopo"'
Autor:
Minna Sopo, Maarit Anttila, Kirsi Hämäläinen, Annukka Kivelä, Seppo Ylä-Herttuala, Veli-Matti Kosma, Leea Keski-Nisula, Hanna Sallinen
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background In many malignancies including ovarian cancer, different angiogenic factors have been related to poor prognosis. However, data on their relations to each other or importance as a prognostic factor in ovarian cancer is missing. The
Externí odkaz:
https://doaj.org/article/c5c886524d45442282fe00d193bfa571
Autor:
Minna Sopo, Hanna Sallinen, Kirsi Hämäläinen, Annukka Kivelä, Seppo Ylä-Herttuala, Veli-Matti Kosma, Leea Keski-Nisula, Maarit Anttila
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241484 (2020)
BackgroundAntiangiogenic therapy, although part of standard treatment in ovarian cancer, has variable efficacy. Furthermore, little is known about the prognostic biomarkers and factors influencing angiogenesis in cancer tissue. We evaluated the expre
Externí odkaz:
https://doaj.org/article/69826e2911394dc789a50d4ef4ac0f56
Autor:
Veli-Matti Kosma, Maarit Anttila, Kirsi Hämäläinen, Leea Keski-Nisula, Minna Sopo, Hanna Sallinen, Annukka M. Kivelä, Seppo Ylä-Herttuala
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241484 (2020)
PLoS ONE
PLoS ONE
Background Antiangiogenic therapy, although part of standard treatment in ovarian cancer, has variable efficacy. Furthermore, little is known about the prognostic biomarkers and factors influencing angiogenesis in cancer tissue. We evaluated the expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6b44c4c85ba0de979545564a935312
https://doi.org/10.1371/journal.pone.0241484
https://doi.org/10.1371/journal.pone.0241484
Autor:
Minna Sopo, Maarit Anttila, Hanna Sallinen, Laura Tuppurainen, Anniina Laurema, Svetlana Laidinen, Kirsi Hamalainen, Pasi Tuunanen, Jonna K. Koponen, Veli-Matti Kosma, Seppo Heinonen, Kari Alitalo, Seppo Yla-Herttuala
Publikováno v:
International journal of cancer. 131(10)
We compared effects of antiangiogenic gene therapy with a combination of soluble sVEGFR-1, sVEGFR-2 and sVEGFR-3 to chemotherapy with carboplatin and paclitaxel and to antiangiogenic monoclonal anti-VEGF-antibody bevacizumab in an intraperitoneal ova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa07133dbf0e5b30e8b61017dd5b122
https://pubmed.ncbi.nlm.nih.gov/22336998
https://pubmed.ncbi.nlm.nih.gov/22336998
Publikováno v:
Journal of Clinical Nursing (John Wiley & Sons, Inc.); Aug2024, Vol. 33 Issue 9, p3513-3525, 13p
Autor:
Sopo, Minna1 (AUTHOR) Minna.Sopo@kuh.fi, Sallinen, Hanna1,2,3,4 (AUTHOR), Hämäläinen, Kirsi5,6 (AUTHOR), Kivelä, Annukka2,4 (AUTHOR), Ylä-Herttuala, Seppo2,4 (AUTHOR), Kosma, Veli-Matti5,6,7 (AUTHOR), Keski-Nisula, Leea1,3 (AUTHOR), Anttila, Maarit1,3 (AUTHOR)
Publikováno v:
PLoS ONE. 11/5/2020, Vol. 15 Issue 11, p1-18. 18p.
Autor:
Sopo, Minna1 (AUTHOR) Minna.Sopo@kuh.fi, Anttila, Maarit1,2 (AUTHOR) Maarit.Anttila@kuh.fi, Hämäläinen, Kirsi3,4 (AUTHOR) Kirsi.m.hamalainen@kuh.fi, Kivelä, Annukka5 (AUTHOR) Kivelaannukka@gmail.com, Ylä-Herttuala, Seppo5 (AUTHOR) Seppo.Ylaherttuala@uef.fi, Kosma, Veli-Matti3,4,6 (AUTHOR) Veli-Matti.Kosma@uef.fi, Keski-Nisula, Leea1,2 (AUTHOR) Leea.Keski-Nisula@kuh.fi, Sallinen, Hanna1,2,5 (AUTHOR) Hanna.Sallinen@kuh.fi
Publikováno v:
BMC Cancer. 6/14/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 2 Color Photographs, 4 Charts, 2 Graphs.